Equity Risk Partners Leads Insurance Due Diligence and Implements New Insurance / Employee Benefits Program for Agena Bioscience, a Portfolio Company of Telegraph Hill Partners

Healthcare and Life Sciences

Company: Agena Bioscience is a San Diego, CA based life sciences and clinical diagnostics company that offers the MassARRAY® System. The system is a highly sensitive, quantitative method for nucleic acid detection via MALDI-TOF mass spectrometry for high-throughput genotyping and mutation profiling for cancer and other disease research, companion diagnostics, pharmacogenomics, epigenetics, clinical genetics, ag-bio genetics, and biobanking molecular sample identification.

MassARRAY uses MALDI-TOF Mass Spectrometry for the detection of nucleic acids and precise quantification of genetic variability. For nearly two decades, this proven platform has delivered highly accurate results, driving biological understanding in clinical and translational research. Cited in over 2,000 peer review journals, Agena's MassARRAY® System is routinely used in premier institutions and companies worldwide for life science, basic research, and agricultural genomics.

Investor: Telegraph Hill Partners, founded in 2001 and based in San Francisco, CA, invests in commercial stage life science, medical technology and healthcare companies.

Equity Risk Partners is the only global, full service insurance, risk management, and employee benefits brokerage focused exclusively on private equity firms, alternative asset managers, and their portfolio companies. Serving private equity firms since 1994, our professionals have had a meaningful impact on more than 1,500 transactions.

If you would like more information please contact Michael Marcon at or (415) 874-7101.